In February 2016, Health Canada approved the daily oral use of the antiretroviral drug Truvada, in combination with safer sex practices, for reducing the risk of the sexual transmission of HIV. The approval is an important step towards the wider use of pre-exposure prophylaxis, or PrEP, for HIV prevention in Canada.
While numerous studies have demonstrated that Truvada as PrEP is a highly effective HIV prevention strategy when used consistently and correctly, many service providers are asking for resources to help them communicate PrEP information to clients and communities, and integrate information on PrEP into programs and services.
Here are a number of resources produced by CATIE and other organizations that can help service providers incorporate PrEP into their HIV prevention work.
Resources for service providers and clients to learn about PrEP basics
Pre-exposure prophylaxis (PrEP) – CATIE’s fact sheet on PrEP focuses on the use of Truvada as oral PrEP, reviewing the evidence on the effectiveness and safety of oral PrEP, access to PrEP, and it’s role within HIV prevention.
Are you prepped for PrEP? – This webinar explains what PrEP is, who it is for, and how it can be accessed.
Oral pre-exposure prophylaxis: Questions and answers – This introduction to PrEP from UNAIDS covers PrEP basics, eligibility, use and implementation.
What is PrEP? - A short and simple video from the United States that uses animation to illustrate how Truvada works in the body to prevent HIV infection.
PrEP – Pre-Exposure Prophylaxis – Introductory information on PrEP presented in question and answer format from the organization REZO in Quebec.
PrEP – Online PrEP information from the AIDS Committee of Toronto (ACT) that can be used to learn more about PrEP and its potential role in a person’s HIV prevention strategy.
PrEP information tailored to specific populations
Resources for clients thinking about taking PrEP
Is PrEP right for me? – From The Stigma Project in the United States this interactive online tool helps people determine if PrEP is a good prevention strategy for them. The tool guides you through a series of questions and makes a recommendation based on your answers following PrEP guidelines from the Centers for Disease Control and Prevention (CDC) in the United States.
Take charge: talk to your provider about PrEP – A brochure from the CDC that provides checklists of activities to do before, during and after a discussion about PrEP with a doctor. It also provides a list of questions about PrEP a client may want to ask their doctor.
POSITIVELY AWARE (PA) PrEP issue – PA is an American not-for-profit HIV/AIDS treatment journal published by Test Positive Aware Network (TPAN). This issue is entirely dedicated to PrEP, covering the basics, research, how to talk to your doctor about PrEP, and real stories of people using PrEP in a variety of situations.
Learning how to address PrEP in community-based service delivery
Guidance for PrEP management in clinical settings
These documents outline how PrEP can be managed in clinical settings. They include recommendations on who should be using PrEP and the prescription, monitoring and discontinuation of PrEP.